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Abstract 
 Every mammalian life develops from one cell after fertilization of an egg by the 
sperm.  The molecular pathways governing this event are still poorly understood.  
Numerous reports indicate that mammalian eggs highly express various protein kinase C 
(PKC) isoforms.  Accordingly, we hypothesize that PKC activity in the egg plays an 
important role during egg-sperm membrane binding and fusion.  In this study, we tested 
our hypothesis in mouse gametes using two types of PKC inhibitors (calphostin c and 
staurosporine) and the typical PKC activator, phorbol ester 12-tetradecanoylphorbol-13 
acetate (PMA).  After treatment with the individual drug, eggs were inseminated with 
sperm.  The sperm binding number (SB) and fusion rate (FR) were scored using light and 
fluorescence microscopy.  By applying the Student’s t-test, we confirmed that the FR and 
SB were significantly decreased after PKC activator or inhibitors treatments.  All treatment 
groups, 1 µM calphostin c, 1 µM staurosporine, or 1 nM PMA showed the significant 
reduction of FR and SB.  Further analysis indicated that the inhibition effects of calphostin 
c and PMA were dose- and time- dependent.  Moreover, under scanning electron 
microscopy (SEM), we observed that the number and shape of microvilli on the PMA-
treated eggs, but not on the calphostin c-treated eggs, was severely changed.  Taken 
together, these results suggest that egg PKC activity plays an important role in the 
signaling regulation of sperm-egg membrane binding and fusion during fertilization. 
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Chapter One 
Introduction 
The inability to conceive is not abnormal in the United States.  About 15 % of 
couples suffer from infertility (53).  This problem stems form various factors such as low 
sperm count or motility, prevention of the egg from being fertilized and delivered to the 
uterus, sexually transmitted diseases, and so forth.  Because more people tend to have 
children at older ages, the risk of the infertility is expected to be larger (53).  In vitro 
fertilization is one of the common solutions for these infertile couples, however, it is 
anticipated, from new findings in this study area, that more simple solutions will be sought. 
All mammalian life begins to develop after sperm-egg membrane fusion.  The 
fertilized egg is implanted on the uterus of the maternal body, starts cell division, and 
develops into an embryo.  The conception requires several steps in the maternal body 
including sperm-egg recognition and union, the fertilized egg’s trip though the fallopian 
tube to the uterus, and the implantation.   
Although these steps are shared by most mammals, the fertilization mechanism of 
the sperm and egg has barely been examined at a molecular level until now.  The 
interaction of the sperm and an egg is the first event to start this series of processes.  By 
understanding this initiation process at the molecular level, we can determine the important 
proteins and signals involved.  Although both the sperm and the egg are responsible for 
this fertilization stage, this study was focused on the egg.  The egg is one of the largest 
cells in the mammalian body, therefore, it is possible to observe the localization of specific 
molecules and treat with specific drugs on a single egg.  For this study, many eggs had to 
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be isolated at one time.  Thus, the mammal chosen for investigating fertilization must have 
certain characteristics.  It should be small, easy to manage, and have enough eggs to be 
isolated.  In this respect, CD-1 mice (common name ICR, known as Institute of Cancer 
Research) were purchased from Charles River labs (Wilmington, Massachusetts).   
Identifying key molecules involved in sperm-egg membrane interaction is an 
intensive research area in the field of reproductive biology.  Much progress has been made 
during the last decade.  CD9, a member of tetraspanin membrane proteins, on the egg 
membrane (63) and Izumo, which is a novel immunoglobulin superfamily protein, on the 
sperm membrane (44) are two factors directly required for binding and fusion of the sperm 
and an egg.  These two proteins are the only two proven requirements for these steps, even 
though an interaction of these two proteins is not reported thus far.  CD9 is mainly 
expressed on the microvillus region of the egg plasma membrane (46).  This microvillus 
region is the place where the sperm and an egg membrane interaction is mediated (25).  
Without CD9 and Izumo, the sperm and the egg cannot fuse with each other and 
conception will not be initiated.  Despite these advancements, the signaling pathways 
inside the sperm and the egg are barely understood thus far.  For this study we focused on 
one signaling pathway inside the egg, the protein kinase C (PKC) signaling.  PKC is a 
superfamily of protein kinases which phosphorylate many other proteins and regulate their 
functions.  The PKC superfamily consists of many isoforms divided into four subgroups, 
conventional PKC (cPKC), novel (nPKC), atypical PKC, and PKC related kinase (PRK) 
(27, 62).  Several PKC isoforms have been reported in the egg (62).  PKC activity is 
known to have an important role for egg meiosis resumption, egg activation, and further 
modification of eggs into zygotes (27, 44, 48).  Many reports suggest involvement of 
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different PKC isoforms during egg activation, but only cPKC is proven to be involved in 
the step.  Although it is known that cPKC activation leads to further development of the 
egg, any significant function of cPKC activity as well as other subgroups in the egg during 
fertilization and initiation of egg activation remains to be explored.   
Calcium ion (Ca2+) plays an important role during mammalian egg activation.  
After fertilization, we can observe repetitive intracellular Ca2+ increase in an egg (35, 45, 
82).  Calcium concentration in cytoplasm is repetitively and transiently raised after sperm 
fusion to an egg (16, 81).  This calcium oscillation causes cortical granule exocytosis, 
which results in fertilization envelope formation (50).  This protein layer makes a physical 
barrier that prevents further sperm fusion to the egg.  Actin is involved in the modification 
of the egg after fertilization and interacts with PKC alpha, one isoform of cPKC (22).  A 
recent study by Halet and his colleagues (36) also shows the close relationship between 
cPKC and calcium oscillation.  From their research, it is expected that the long-term 
calcium level may be maintained by cPKC activity (36).  Because the vigorous activity of 
PKC has been demonstrated inside the egg, we hypothesize that PKC is also involved in 
gamete membrane binding and fusion.  To determine the importance of PKC activity 
during sperm-egg fertilization, various PKC activators and inhibitors were used to treat the 
mouse eggs.  The ability of fusion and binding of the egg was then tested by in vitro 
fertilization (IVF).  The collected results will determine the role, if any, of specific PKC 
isoforms in the sperm-egg binding and/or fusion.  Moreover, PKC activity is expected to 
regulate actin-supported microvilli and CD9 which is localized on microvilli and 
physically attached by PKC on the egg (46, 55, 98).  The morphological structure of the 
egg plasma membrane will also be viewed by scanning electron microscopy after drug 
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treatment. 
This experiment aims specifically at the sperm-egg binding and fusion.  So the 
eggs used in this experiment are zona-free eggs, which zona pellucida is chemically 
removed from the egg.  Zona pellucida is the polymers of three glycoproteins forming the 
gel layer around the egg (24, 73).  It induces acrosome reaction on the sperm and allows 
the sperm to go through this jelly layer (23, 64).  It also protects the egg from multiple 
fertilizations by sperm (polyspermy) (92).  To observe the pure interaction of sperm and 
egg membrane, we removed this outer layer.  So the sperm binding and fusion number is 
not affected by the functions of zona pellucida. 
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Objectives 
The objectives of this study are: 1) to determine the fertilization ability of zona-
free mouse eggs after PKC activation or inhibition inside the eggs; 2) to determine whether 
there is an alteration of structure and localization of actin, CD9, chromosomal DNA, and 
microvilli after PKC activation or inhibition in the zona-free mouse egg.  Regulation of 
PKC is thought to play a critical role in the egg’s ability to bind and fuse with the sperm.  
Clarifying the effects of PKC activation and inhibition in the egg will further our 
understanding of the egg’s signaling pathways during fertilization. 
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Specific Aims 
PKC is involved in meiosis resumption and further egg activation.  It is also the 
key regulator for biological activities of many target proteins in a cell.  PKC is expected to 
have an important role during fertilization.  Therefore, the goal of this study is to determine 
any alteration of fertilization ability of the mouse egg when PKC is activated or inhibited, 
and to determine any alteration of the structures of the important molecules (actin, CD9, 
chromosomal DNA, and microvillus) of the egg during fertilization. 
 
Specific Aim 1 
To determine the effects of PKC activation or inhibition in the mouse egg during 
gamete membrane interaction. 
Hypothesis: PKC activation or inhibition blocks sperm binding and 
fusion to the egg. 
 
Specific Aim 2 
To determine the molecular and structural alternations in the mouse egg after PKC 
activation or inhibition. 
Hypothesis: Both PKC activation and inhibition change the 
localization and the extent of some fertilization-related molecules and 
structures. 
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Chapter Two 
Review of Literature 
INTRODUCTION 
 This chapter briefly reviews reported studies about this area of research.  The 
sections are consisted of three parts: 
One: Important molecules participating in sperm-egg membrane interaction and 
further embryonic development 
Two: Protein kinase C (PKC) as the important signaling molecules inside the egg 
during egg activation 
Three: CD-1 (ICR) mice as an experimental model for the investigation of IVF 
 
Important molecules participating in sperm-egg membrane interaction and further 
embryonic development 
 The molecular and cellular mechanisms underlying sperm-egg fertilization have 
begun to be unfolded in the last two decades and still are being extensively explored.  
Since this event consists the interaction of two kinds of cells, studies on both the sperm and 
the egg are necessary to understand this phenomenon.  First of all, the acrosome reaction 
(AR) is the process by which the sperm acquires the fertilization competency.  AR 
modifies the sperm membrane proteins and the sperm membrane, thus enables the sperm to 
fertilize an egg (72).  The freshly ejaculated sperm is unable to fertilize without undergoing 
AR (72).  This process is initiated when a sperm attaches to the zona-pellucida of the egg 
in vivo.  It also can occur spontaneously after 2 hours capacitation in a suitable culture 
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medium in vitro (37, 84).  This process is required for the sperm to penetrate though the 
zona pellucida of the egg by producing nitric oxide synthase (NOS) (11).  NOS enhances 
the motility and AR of sperm which allow the sperm to fertilize with egg the effectively 
(38, 74).  On the other hand, oocytes undergo maturation steps inside the maternal body, 
but their meiosis is arrested at the second metaphase (MII).  When oocytes reach this phase, 
they are defined as “egg” (59).  The MII eggs do not experience further activation without 
sperm fusion.  Several key cellular events follow sperm-egg fusion, activation of the egg, 
resumption of the egg meiosis, pronuclear formation, and initiation of the early embryonic 
development, among others. 
However, little is known about fertilization at the molecular level.  To date, only 
two proteins are known to be required factors during sperm-egg fusion, Izumo on the 
sperm membrane and CD9 on the egg membrane.  A Japanese research group recently 
reported that sperm from Izumo-knockout male mice are infertile (44).  Sperm from Izumo 
knockout mice cannot fuse with the egg in vitro, thus proving that the Izumo protein on the 
sperm membrane is essential for sperm fusion with the egg.  The gene encoding Izumo was 
identified from crude sperm protein by gel electrophoresis and immunoblotting.  A human 
homologue was an unverified gene in the National Centre for Biotechnology Information 
(NCBI) database.  The predicted protein size was 56.4 kDa on mouse sperm and 37.2 kDa 
on human sperm.  This protein was detectable only after the AR of the sperm.   
CD9 knockout mice were also generated but only CD9 knockout females were 
infertile (18).  The eggs from CD9 knockout female mice cannot be fused with sperm in 
vitro (34).  CD9 is a member of the tetraspanin family.  Proteins in this family have four 
transmembrane domains.  Zhu and colleagues (99) reported the requirement of the large 
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extracellular loop of CD9 for fertilization.  Using microinjection, injection of Izumo 
knockout sperm into a wild type egg or wild-type sperm into a CD9 knockout egg resulted 
in normal egg activation and further development of the resulting embryo to term.  The 
derived offspring had no physical difference from wild-type mice (18, 44).  Therefore, 
these two proteins are currently confirmed as required molecules (fusion factors) 
specifically involved in the process of sperm-egg fusion.  These data indicate that each is 
necessary but not that the pair alone is sufficient for fertilization. 
The discovery of these two important molecules involved in fertilization has led to 
further questions.  What are the signaling pathways that regulate these molecules? What 
signaling pathways are activated or inhibited after fertilization? To explore these questions, 
we focused on PKC activity in mouse eggs.  Because an egg is one of the biggest single 
cells in an organism, molecular localization and structural changes can be observed and 
analyzed with simple instruments.  Zona pellucida is the final mechanical barrier to sperm 
(6).  Because of this property, we need to remove zona pellucida for certain observation of 
sperm-egg membrane interaction. 
 
Protein kinase C (PKC) as an important signaling pathway during egg activation
 PKC is a family of serine/threonine kinases, which are enzymatic proteins that 
phosphorylate other target proteins to stimulate their cellular activity (47, 66).  PKC 
comprises four subgroups based on differences in activation sites (86).  The four subgroups 
are as follows: conventional PKCs (cPKC: PKCα, PKC β and PKCγ), atypical PKCs 
(aPKC: PKCδ, PKCε, PKCη, and PKCθ), novel PKCs (nPKC: PKCζ, PKCι, and PKCλ), 
and PKC-related kinases (PRK).  These subgroups are regulated by multiple activators 
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including calcium ion, diacylglycerol, and phosphatidylserine (Fig. 1-1).  Many 
mechanisms and signaling pathways involving PKC activity have been described (76, 97).   
One reason for studying PKC is that it is targeted by diacylglycerol and 
phosphatidylserine, which are components of the cellular membrane.  Because fertilization 
is completed by gamete membrane interaction (gamete membrane binding and fusion) the 
involvement of PKC activity is a strong possibility.  Moreover, one previous study (98) 
showed the association of PKC and CD9 after classical PKC activation by phorbol 12-
myristate 13-acetate (PMA).  Therefore, PKC activity may contribute to the signaling 
pathway(s) in the egg during sperm-egg membrane binding and fusion.   
Many studies have investigated the significance of PKC activity in oocyte 
maturation and egg activation.  Before oocyte is completely matured to a secondary oocyte, 
meiosis has to be resumed and prophase I to be finished (29).  Germinal vesicle breakdown 
(GVBD) is one of the important steps during the final stage of oocyte maturation.  PKC 
activation of mouse oocytes inhibit GVBD (26), but PKC activation by 12-myristate 13-
acetate (PMA) stimulates further egg activation at the MII stage (58).  Early events of 
oocyte activation, e.g., second polar body emission and pronuclear formation, are 
restrained after inhibition of PKC activity (27).  Furthermore, most PKC isoforms are 
required for egg activation and the early stage of embryonic development (19, 27, 49).  
These findings indicate important and very complex activities of PKC during oocyte 
maturation and egg activation.  Although this signaling pathway has been investigated in 
many studies, PKC activity in the regulation of sperm-egg membrane binding and fusion 
has not been explored. 
There are many commercially available PKC activators and inhibitors.  PMA and 
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1,2-Dioctanoyl-sn-glycerol (DiC8) are used as PKC activators, and calphostin c, 
staurosporine, (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl) cyclohexane carboxamide 
dihydrochloride (Y-27632), 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-
indolo(2,3-a) pyrrolo (3,4-c)-carbazole (Gö 6976), and 2-[1-(3-Dimethylaminopropyl)-5-
methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö 6983) are used as PKC inhibitors.  
These chemicals target different PKC isoforms, so that the specific PKC isoform(s) playing 
an important role during fertilization of mouse gametes may be identified.   
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Figure1-1. Schematic structures of four PKC subgroups.   
Each group has distinct regulatory and catalytic domains.  To be activated, cPKC requires 
DAG and calcium ion; nPKC requires DAG; aPKC requires phosphatidylserine; and PRK 
requires Rho.  ATP is an obligatory factor for all PKC isoforms to be stimulated.   
(DAG: Diacylglycerol) 
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Figure 1-2. The structure of Phorbol 12-myristate 13-acetate (68).   
It activates traditional PKC subgroups (cPKC and ｎPKC) by binding DAG 
binding site (80). 
 
Figure 1-3. The structure of 1,2-Dioctanoyl-sn-glycerol (1).   
It activates traditional PKC subgroups by binding DAG binding site (80) 
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Figure 1-4. The structure of calphostin c (13).   
It is from Fungi Cladosporium cladosporioides, activated by light and a very 
specific PKC activator (13). 
Figure 1-5. The structure of staurosporine (79).   
It is from bacteria Streptomyces sp.  It inhibits many protekin kinases inside a 
cell (39, 71). 
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Figure 1-6. The structure of 12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-
indolo(2,3-a) pyrrolo (3,4-c)-carbazole (Gö 6976) (30).   
It is known to inhibit cPKC activity, but other subgroups are potentially inhibited (51, 77). 
 
 
 
Figure 1-7. The structure of 2-[1-(3-Dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-
indol-3-yl) maleimide (Gö 6983) (34).   
It is known to inhibit PKC activity except PRK (34). 
 
 
Figure 1-8. The structure of (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl) cyclohexane 
carboxamide dihydrochloride (Y-27632) (96). 
It is known to inhibit PRK activity by binding ATP binding site (96). 
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CD-1 (ICR) mice as an experimental model for the investigation of in vitro fertilization 
 Sperm-egg membrane binding and fusion are shared by all mammals as the part of 
reproduction event.  To explore the underlying mechanisms, it is required that we can 
obtain enough numbers of eggs as needed from the animal.  We also need to consider 
husbandry and fecundity of the animal.  ICR (Institute of Cancer Research, where this 
mouse strain was developed) mice from Charles River Laboratories were used as the 
experimental model in this research.  This strain was Swiss origin and established in 1926 
from 9 albino mice by Dr. Clara Lynch (83).  Mating and breeding of this strain results in 
more pups at a time comparing with normal non-albino mouse strain.  Generally speaking, 
each ICR mouse can ovulate about 25 eggs after being injected with pregnant mares’ serum 
gonardotropin (PMSG) and human chorionic gonardotropin (hCG) in our laboratory.  
Sacrificing 6 mice at each experiment, we were able to collect at least 60 eggs, which were 
enough to make more than 3 groups of experiments with more than 15 eggs per group.  
Thus, this experimental model is one of the best animal models to facilitate this 
fertilization research. 
 In our experiments, 8-week old ICR mice were purchased from the commercial 
vendor and normally spent 2 weeks in the animal facility of Marshall University to 
accommodate the new environment before being used for egg isolation.  We injected two 
hormones PMSG and hCG into the mice to stimulate ovulation.  The best egg numbers 
were obtained from the oviducts of the mice that were sacrificed 13.5 hours after hCG 
administration, which should be given at 47.5 after first PMSG injection.  When the mice 
were sacrificed more than 14 hours after hCG injection, we had problems to remove zona 
pellucida from the eggs. 
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 All animal care and use procedures described within were reviewed and approved 
by the Institutional Animal Care and Use Committee of Marshall University, and were 
performed in accordance with the Guiding Principles for the Care and Use of Laboratory 
Animals. 
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Abstract 
 Every mammalian life develops from one cell after fertilization of an egg by the 
sperm.  The molecular pathways governing this event are still poorly understood.  
Numerous reports indicate that mammalian eggs highly express various protein kinase C 
(PKC) isoforms.  Accordingly, we hypothesize that PKC activity in the egg plays an 
important role during egg-sperm membrane binding and fusion.  In this study, we tested 
our hypothesis in mouse gametes using two types of PKC inhibitors (calphostin c and 
staurosporine) and the typical PKC activator, phorbol ester 12-tetradecanoylphorbol-13 
acetate (PMA).  After treatment with the individual drug, eggs were inseminated with 
sperm.  The sperm binding number (SB) and fusion rate (FR) were scored using light and 
fluorescence microscopy.  By applying the Student’s t-test, we confirmed that the FR and 
SB were significantly decreased after PKC activator or inhibitors treatments.  All treatment 
groups, 1 µM calphostin c, 1 µM staurosporine, or 1 nM PMA showed the significant 
reduction of FR and SB.  Further analysis indicated that the inhibition effects of calphostin 
c and PMA were dose- and time- dependent.  Moreover, under scanning electron 
microscopy (SEM), we observed that the number and shape of microvilli on the PMA-
treated eggs, but not on the calphostin c-treated eggs, was severely changed.  Taken 
together, these results suggest that egg PKC activity plays an important role in the 
signaling regulation of sperm-egg membrane binding and fusion during fertilization. 
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Introduction
 Sperm-egg membrane binding and fusion is a critical event, initiating the 
development of a new life, but the molecular signaling pathways governing this event are 
barely explored.  The protein kinase C (PKC) signaling pathway has been shown to play an 
important role in diverse cellular processes, such as, cell differentiation, cell growth, and 
cell death (3, 43, 62, 89).  In addition to these essential roles, oocyte maturation and egg 
activation are also regulated by PKC activity (27).  There are four broad PKC subfamilies 
consisting of 13 isoforms; conventional PKC (cPKC; PKCα, PKCβ, and PKCγ), novel 
PKC (nPKC; PKCδ, PKCε, PKCη, and PKCθ), atypical PKC (aPKC; PKCζ, PKCι, and 
PKCλ), and PKC-related kinase (PRK) (62).  These four subfamilies have different modes 
of regulation for their activity.  Each activator binds to the regulatory domains of the target 
PKC isoforms, which allows the substrate to bind with catalytic domain of the PKC.  
cPKC requires 1,2-diacylglycerol (DAG) and calcium ion (Ca2+).  nPKC requires DAG or 
phorbol esters.  aPKC requires Phosphatidylserine.  PRK requires Rho (3,62, 89).  Rho is a 
family of GTP-binding proteins and modifies the actin cytoskeleton (9).  A variety of PKC 
isoforms, have been confirmed in mouse eggs (28, 58).   
 Ca2+ inside the egg is also an important signaling molecule.  Germinal vesicle stage 
mouse oocytes do not continue maturation to pronuclear formation after Ca2+ chelation (5).  
The Ca2+ level inside the egg is dramatically increased after fertilization with sperm (67), 
leading to cortical granule exocytosis (CGE) at the point of sperm fusion (49, 54, 67).  
When eggs are treated with Ca2+ chelator, CGE and second polar body formation are 
inhibited (49), and an increase in the number of polyspermy is observed (61).  Both Ca2+ 
independent PKC, and Ca2+ dependent PKC are involved in early egg activation (85).  
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These data suggest that the increase in Ca2+ concentration is probably related to the PKC 
signaling inside the eggs, stimulaing maturation and activation of mouse oocytes. 
In the present study, we particularly focus on the egg PKC activity relevant to 
fertilization.  PKC activity constitutes the necessary signaling pathway for the egg just 
before and immediately after fertilization.  Moreover, PKC is recruited to the inner cell 
membrane in order to be activated inside the cell (3, 43, 62, 89).  Accordingly, we 
hypothesize that PKC is a requirement for sperm-egg membrane binding and fusion.   To 
test this, the effects of PKC activation and inhibition were examined.  Eggs were treated 
with either a PKC activator or a PKC inhibitor before insemination, and then the egg’s 
ability to fertilize was assessed.  Staurosporine and calphostin c (PKC inhibitors), and 
PMA (a PKC activator), were applied.  Staurosporine inhibits protein kinases, such as, 
protein kinase A (PKA), PKC, and protein kinase G (PKG) (39).  Calphostin c competes 
and binds with DAG and phorbol ester binding sites (31), inhibiting the classic PKC 
isoforms (4, 12, 31, 56, 77).  PMA is a phorbol ester required for activating classical PKC 
isoforms (cPKC, nPKC, and aPKC) (62).  Both Ca2+ dependent and independent PKCs are 
activated by PMA (2, 95). 
 PKC is involved in and regulates many signaling pathways in a variety of cell types 
(3, 43, 62, 87, 89).  We speculate that this drug-altered activity in the egg also leads to 
cellular responses other than fertilization events.  Actin, CD9, and chromosomal DNA are 
known as important molecules involved in egg activation and maturation (61, 20, 46, 63, 
69).  Actin is a main component of the cytoskeleton and plays various functions in the cell.  
These functions include strengthening the cell, organizing the organelles, and controlling 
cell division (48, 94).  In the egg, actin has been shown to function in the adhesion of 
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sperm to the egg and the formation of a polyspermy shield (61, 90).  The actin polymer, F-
actin is easily stained by phalloidin conjugated with a labeling dye, rhodamine.   
CD9 is associated with microvilli, and is the only egg membrane protein which is 
confirmed as a required molecule for sperm-egg fusion (46, 63).  Eggs from CD9 knockout 
female mice or those treated with the CD9 monoclonal antibody KMC8 are not able to fuse 
with sperm.  In somatic cells, translocation of cPKC to the plasma membrane forms a 
physical association with CD9 (98).  These data suggest that PKC may associate with and 
regulate CD9’s function, which, in turn, regulates the egg’s fertilization ability.  It is our 
hypothesis that changes in the localizations and/or structures of actin, CD9, chromosomal 
DNA, and microvilli will be observed after PKC activation or inhibition.  By analyzing the 
cellular dynamics of these molecules, we will determine the importance of PKC signaling 
in fertilization. 
In this study, to test the effects of PKC signaling, the egg surface and some 
molecules involved in the egg fertilization and activation are examined after PKC 
activation/inhibition. 
 
Methods and Materials 
Collection of eggs and sperm cells 
MII phase oocytes were isolated from 8 to 10 weeks old ICR (65) mice into 100 µl 
of M199 Medium containing 0.3 % bovine serum albumin (BSA; Medium 1).  Female 
mice were superovulated by intraperitoneal injection of 10 i.u. (100 µl of 100 i.u./ml) of 
pregnant mares’ serum gonadotropin (PMSG) into female mice.  After 48 hours, 10 i.u. 
(100 µl of 100 i.u./ml) of human chorionic gonadotropin (hCG) was injected 
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intraperitoneally.  Approximately 13-14 hours post-hCG injection, mice were sacrificed by 
suffocation (CO2 incubation in a plastic box at room temperature) for 2 minutes.  The 
oocytes surrounded by cumulus cells were obtained from the oviducts.  Hyaluronidase 
(300 µg / ml) treatment for 5 minutes was used to release the cumulus masses, followed by 
chymotrypsin (30 µg / ml) treatment for 3 minutes to remove the zona pellucida from the 
oocytes.  Using a zona-pipette (appendix A), we applied physical pressure to the zona 
pellucida to obtain zona-free eggs.  These zona-free eggs were stored in 100 µl of Medium 
1 at CO2 incubator (37 °C, 5% CO2).  A mouth pipette was used to transfer the eggs in the 
in vitro fertilization experiments.  After each drug treatment, the eggs were washed three 
times with 100 µl of Medium 1 (appendix A).  All drug treatments were completed in 
Medium 1. 
After 8 to 12 weeks male mice were sacrificed by suffocation, caudal epididymis 
and vas deferens were obtained.  Sperm were isolated from the caudal epididymis and vas 
deferens by placed and chopped in 500 µl of M199 Medium with 3 % BSA (Medium 2).  
The concentration of sperm in the medium was approximately 1 × 107 sperm / ml after 
sperm isolation from one male mouse.  Because the sperm acrosome reaction is required 
before sperm fusion to the egg (75), sperm were capacitated (changes that enable sperm to 
undergo both the acrosome reaction and hyperactivation.) for two hours in 500 µl of 
Medium 2 in the CO2 incubator.  Sperm were diluted (1:10) from the original concentration 
to get the sperm concentration at 1 × 106 sperm / ml. 
 
Drug Treatments of the eggs 
All drugs used in this experiment are dissolved in dimethyl sulfoxide (DMSO).  
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Therefore DMSO treatment is used as the control group.  After a 60 minutes resting 
interval, zona-free eggs were incubated with 1 µM calphostin c or 1 % DMSO in 100 µl of 
Medium 1 for 60 minutes.  After three times washing with Medium 1, eggs were incubated 
with DAPI for 15 minutes and washed three times.  The same procedure was applied to 
staurosporine and PMA treatments.   
 
In Vitro Fertilization (IVF) 
Ten µl of sperm (1 × 106 sperm / ml) from the capacitated medium were transferred 
into 100 µl of Medium 1 containing the drugtreated eggs (10:110 dilution of the sperm: 
approximately 1 × 105 sperm cells in the insemination medium).  Fourty minutes after 
insemination, eggs were washed three times with Medium 1 to remove nonspecific sperm 
binding.  Eggs were then fixed with 3.7% formaldehyde for 15 minutes and observed 
under 200 × magnification.  Sperm binding numbers and fusion numbers were counted.  
Under the phase contrast mode, the sperm tails attached to an egg were counted and 
defined as the sperm binding number (SB).  Under the fluorescence mode, the number of 
chromosomal DNA stained with DAPI, excluding the egg chromosomal DNA, was defined 
as the sperm fusion number.  The fertilization rate (FR) was defined as the percentage of 
the eggs fused with at least one sperm.  The fertilization index (FI) was defined as the 
mean number of fused sperm per egg.   
At least 15 eggs per sample group were prepared to normalize the each result.  We 
repeated the IVF assays with calphostin c for five times, staurosporine for four times, and 
PMA for three times.  Eggs and sperm were stored in a CO2 incubator (37 °C and 5% CO2) 
during all incubation steps. 
Hiroto Akabane 25 5/3/2006 
Staining and immunocytochemistry of eggs by fluorescence microscopy (Triple staining) 
After individual drug treatment, eggs were stabilized on a glass slide by incubation 
in M199 Medium without BSA for 30 minutes in a CO2 incubator.  Once the eggs were 
stacked on the glass, they were treated with 3.7 % formaldehyde in Medium 1 for 15 
minutes.  After fixation, they were incubated with rat anti-CD9 monoclonal antibody 
(KMC8; 50 ug/l final concentration) for 60 minutes and it is washed out though Medium 1 
for three times, followed by the incubation with the goat anti-rat IgG antibody (20 ug/l) 
conjugated with FITC for 45 minutes.  Then they were washed three times with Medium 1 
and soaked in 1 % DAPI for 15 minutes to stain the chromosomal DNA and washed three 
times with Medium 1.  Subsequently, the eggs were treated with 0.1 % triton-X 100 for 1 
minute to permeabilize the membrane and washed three times with Medium 1.  Finally, the 
eggs were incubated with rhodamine-phalloidin (2 ug/ml) for 15 minutes to stain the actin 
cytoskeleton and washed three times with Medium 1.  The eggs were kept in Medium 1 at 
all times during these steps.  Fluorescent signals of chromosome (blue), actin (red), and 
CD9 (green) were visualized under fluorescence microscopy. 
 
Scanning Electron Microscopy (SEM) 
Following each drug treatment, eggs were transferred on to a glass slide holding 50 
µl of M199 Medium without BSA.  After 30 minutes incubation in the CO2 incubator, eggs 
were stabilized on the glass.  Eggs were fixed with a 2.5 % glutaraldehyde solution (in 0.1 
M sodium cacodylate, pH 7.3) overnight, and then treated with a 1 % osmium tetroxide 
solution (in 0.1 M sodium cacodylate, pH 7.3) for 1 hour.  After washing with 0.1 M 
sodium cacodylate, the eggs were dehydrated by serial ethanol dehydrating steps (50 %, 
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70 %, 80 %, 95 %, and 100 %) in 70 µl volume.  The eggs were soaked in each 
concentration of ethanol for 15 minutes.  The ethanol concentration was increased step by 
step.  Dehydration with 100 % ethanol was repeated three times to completely dehydrate 
the sample.  The slide was put into a plasma coater, and sputter coated with gold / 
palladium in argon gas.  The coated eggs were examined under SEM with a magnification 
of 3,500 × or15,000 × to observe the plasma membrane surface of the egg. 
 
Results 
IVF after PKC inhibition and activation 
A. PKC inhibition 
Because all drugs used in this study were dissolved in DMSO (table. 2-1), DMSO-
treated eggs were always used as the control group to compare with the eggs treated with 
the drugs.  From the previous studies, 1 % DMSO treatment on eggs has no effect on the 
egg’s fertilization ability (16, our unpublished results).  After PKC inhibition by 1 µM of 
calphostin c, sperm binding and fusion numbers were significantly decreased (Fig. 2-1).  
We observed a clear difference between DMSO and calphostin c treated eggs under the 
fluorescence microscope (Fig. 2-5).  On the other hand, even though there was a significant 
decrease of FR, FI, and SB after the staurosporine treatment (Fig. 2-2), this decrement was 
not as dramatic as that seen in the calphostin c treatment. 
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Drug Name Activator / Inhibitor Target PKC isoforms Stock Concentration 
Calphostin c Inhibitor cPKC, nPKC, aPKC 100 µM 
DiC8 Activator cPKC, nPKC 5 mM 
Gö 6976 Inhibitor cPKC, PKCγ, PRK 100 µM 
Gö 6983 Inhibitor cPKC, nPKC, aPKC 100 µM 
PMA Activator cPKC, nPKC 200 nM 
Staurosporine Inhibitor cPKC, nPKC, aPKC 100 µM 
Y-27632 Inhibitor PRK 200 µM 
 
Table 2-1. Characteristic and stock concentration of drugs used in this experiment. 
Depending on the drug, its strength for the effective concentrations are different, so 
their stock concentrations were also different (71, 96). 
 
To determine the efficiency of PKC inhibition by calphostin c, treatments with 
different time increments (15, 30, and 60 minutes) were tested.  The same inhibition effects 
were observed for all treatments at 15, 30, and 60 minutes (Fig. 2-6).  Since 30 minutes 
treatment effectively inhibited both SB and FR (Fig. 2-6), eggs were treated with 
calphostin c for 30 minutes instead of 60 minutes hereafter.  To determine whether the 
inhibition of calphostin c was dose-dependent, different concentrations of calphostin c (100 
nM, 500 nM, and 1 µM) were tested.  Sperm binding numbers and fusion rates were both 
decreased as the inhibitor concentration was increased (Fig. 2-7), suggesting that the 
inhibition effect of calphostin c on the egg’s fertilization ability is dose-dependent and 
specific. 
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 Because there was significant blockage of sperm binding and fusion in the 
calphostin c treated eggs, we want to know which PKC isoform(s) have an important role 
in the regulation of these fertilization steps.  For this purpose, we used three other PKC 
inhibitors to treat the eggs before IVF: (R)-(+)-trans-4-(1-Aminoethyl)-N-(4-Pyridyl) 
cyclohexanecarboxamide dihydrochloride (Y-27632), 12-(2-Cyanoethyl)-6,7,12,13-
tetrahydro-13-methyl-5-oxo-5H -indolo(2,3-a) pyrrolo(3,4-c)-carbazole (Gö 6976), and 2-
[1-(3-Dimethylaminopropyl)-5- methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö 
6983).  Each drug has a unique target site, therefore, inhibiting different PKC isoforms (31, 
77).  Y-27632 effectively inhibits Rho-dependent protein kinases, ROCK-I, ROCK-II, and 
PRK2 (17, 89).  Gö 6976 is competitive to the ATP binding site of Ca2+-dependent PKC 
(33), so it selectively inhibits cPKC (7, 17, 33, 77).  Gö 6983 inhibits all PKC isoforms 
except PKCµ (34, 88); this drug is useful to differentiate PKC µ activity from other PKC 
activities.  Gö 6976 (1 µM; targets cPKC) and Gö 6983 (1 µM; targets cPKC, PKCδ, and 
PKCζ) were used, instead of calphostin c, to inhibit different PKC isoforms in the egg.  
Surprisingly, we did not see any inhibition in sperm binding and fusion (Fig. 2-4).  Further 
experiments are needed to address this discrepancy.  However, we did find an interesting 
result.  After eggs were treated with 2 µM of Y-27632, the polyspermy percentage (the 
percentage of the eggs with more than one fused sperm) was significantly reduced to 30.7 
± 17.1 %, compared with the control’s  polyspermy percentage of 69.2 ± 11.3 % (n=4, p < 
0.02).   
 
B. PKC activation 
To determine the regulation of fertilization by PKC signaling, a PKC activator was 
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applied to the eggs and their fertilization ability was observed.  Surprisingly, as we saw in 
the eggs treated with either calphostin c or staurosporine, the eggs treated with 2 nM of 
PMA showed significant blockage of sperm binding and fusion to an egg.  FR, FI, and SB 
were all significantly reduced (Fig 2-3).  Time-course experiments showed that the PMA 
treatment significantly inhibited sperm binding and fusion after 30 minutes treatment (Fig. 
2-6).   The dose-response curve clearly demonstrated that the treatment with 1 nM of PMA 
for 30 minutes effectively decreased the SB and FR (Fig. 2-7).  Since PKC activation in 
eggs by PMA showed dramatically reduced sperm binding and fusion, another broad PKC 
activator, 1,2-Dioctanoyl-sn-glycerol (DiC8) was also tested.  DiC8 mimics phorbol esters, 
which are required for activation of classical PKC isoforms (34).  Eggs treated with 50 µm 
of DiC8 for 30 minutes did not show any significant changes in all FR, FI, and SB (Fig. 2-
3).  Some eggs were lysed in the medium, and others became very fragile and lysed when 
transferred (table 2-2).  Increasing the concentration of DiC8 to 100 µM even caused 
higher percentage of egg death (103 out of 156 eggs died, 66 %).   A much lower 
concentration of DiC8 will be tested in the future. 
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Figure 2-1. Fertilization rate, fertilization index, and sperm bound of DMSO- and 
calphostin c-treated eggs.  After 1 µM calphostin c treatment, the eggs lost the ability to 
bind and fuse with sperm.  FR, FI, and SB all were significantly decreased after either the 
calphostin c treatment or the PMA treatment.   (A) FR of these two groups.  The values 
were 75.6 ± 9.6 % (DMSO) and 6.0 ± 3.4 % (calphostin c) (p < 0.001).  (B) FI of these two 
groups.  The numbers were 1.27 ± 0.34 (DMSO) and 0.066 ± 0.036 (calphostin c) (p < 
0.01).  (C) SB of those two groups, 5.48 ± 0.81 (DMSO), 0.34 ± 0.15 (calphostin c) (p < 
0.001). 
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Figure 2-2. Fertilization rate, fertilization index, and sperm bound of DMSO- and 
staurosporine-treated eggs.  After 1 µM staurosporine treatment, the eggs’ ability to bind 
and fuse with sperm was drastically decreased.  There were significant differences between 
the DMSO and staurosporine group in all three values of FR, FI, and SB.  (A) FR of these 
two groups.  The values were 58.8 ± 7.4 % (DMSO) and 24.8 ± 3.3 % (staurosporine) (p < 
0.005).  (B) FI of these two groups.  The numbers were 0.79 ± 0.22 (DMSO) and 0.26 ± 
0.06 (staurosporine) (p = 0.04).  (C) SB of those two groups, 9.62 ± 2.22 (DMSO) and 3.83 
± 1.15 (staurosporine) (p = 0.03).    
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Figure 2-3. Fertilization rate, fertilization index, and sperm bound of DMSO- and PMA-
treated eggs.  After 2 nM PMA treatment, the eggs lost the ability to bind and fuse with 
sperm.  FR, FI, and SB all were significantly decreased after the PMA treatment.   (A) FR 
of these two groups.  The values were 71.0 ± 12.9 % (DMSO) and 2.2 ± 2.2 % (PMA) (p < 
0.005).  (B) FI of these three groups.  The numbers were 1.19 ± 0.33 (DMSO) and 0.03 ± 
0.02 (PMA) (p < 0.01).  (C) SB of those three groups, 9.82 ± 3.33 (DMSO) and 0.81 ± 
0.17 (PMA) (p < 0.01).   
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Figure 2-4. Fertilization rate, sperm bound, and fertilization index to the eggs treated with 
DMSO, Gö 6976, Gö 6983, or DiC8.  There were not significant differences between 
DMSO and drug treatment groups in all three values of FR, FI, and SB.  (A) FR of these 
four groups.  The values were 75.6 ± 3.2 % (DMSO), 77.9 ± 1.2 % (Gö 6976), 73.2 ± 
2.5 % (Gö 6983), and 75.0 ± 3.8 % (DiC8).  (B) FI of these four groups.  The numbers 
were 1.32 ± 0.11 (DMSO), 1.73 ± 0.20 (Gö 6976), 1.18 ± 0.08 (Gö 6983), and 1.13 ± 0.32 
(DiC8).  (C) SB of those four groups, 6.56 ± 0.67 (DMSO), 8.64 ± 2.68 (Gö 6976), 8.09 ± 
0.76 (Gö 6983), and 6.09 ± 0.22 (DiC8).   
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Figure 2-5. Microscopic images of the DMSO-treated (A and B) and calphostin c-treated 
(C and D) eggs.  The phase contrast image of DMSO-treated eggs (A) shows many sperm 
binding (SB) to the eggs.  In contrast, no SB is seen in the phase contrast image of 
calphostin c-treated eggs (C).  Blue dots show chromosomal DNA stained by DAPI in the 
fluorescence image of the DMSO-treated eggs (B) and the calphostin c-treated eggs (D).  
More than two dots are observed in each egg in picture B, but all eggs have only one 
chromosomal DNA dot in picture D.  This means that there is no sperm fusion to the eggs 
treated with calphostin c.  Polyspermy eggs with three or more blue dots (indicated by 
arrows) are also observed in picture B. 
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Figure 2-6. Changes in sperm binding and fusion rate over the time course of 1 µM 
calphostin c (A) or 2 nM PMA (B) treatment.  As the treatment time increases the SB and 
FR decreases.  Each tested group contained at least 20 eggs and was repeated three times.   
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 Figure 2-7. The dose-response curve after 30 minutes exposure to calphostin c (A) or 
PMA (B) treatment.  SB and FR of the calphostin c-treated eggs gradually decreased as 
concentration increased.   In contrast, both SB and FR of PMA-treated eggs were suddenly 
blocked at 1 nM of PMA.  30 minutes treatments were applied to all experiments.  Each 
tested group contained at least 20 eggs and was repeated three times.   
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A B
Figure 2-8. Microscopic images of the eggs after insemination with sperm then followed 
by 2 nM PMA treatment for 60 minutes.  Egg pictures are of phase contrast (A) and DAPI 
fluorescence (B).  No sperm tails were observed in picture A, indicating no sperm binding 
to the eggs.  All eggs showed only egg chromosomal DNA in picture B, indicating no 
fusion of sperm to the eggs. 
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Treatment 
 (40 minutes) 
fertilized eggs # 
(FR) 
fused sperm #  
(FI) 
sperm bind #  
(SB) 
Total egg # 
 
DMSO 138 (72.6 %) 219 (1.15) 1468 (7.73) 190 
50 µM DiC8 120 (65.2 %) 210 (1.14) 1477 (8.03) 184 
100 µM DiC8 103/156 (66.0 % of eggs lysed) 156 
 
Table 2-2. Fertilization ability of the eggs treated with DiC8.  There was no statistical 
difference between the DMSO- and DiC8-treated group (P=0.21).  The eggs treated with 
100 µM DiC8 intent to die in the medium.  The egg membrane became delicate to physical 
stress.  The transferring procedure broke some cells and movement of the medium 
provoked cell lysis. 
 
Localization of chromosomal DNA, actin, and CD9 after PKC inhibition or activation 
It is possible that PKC activity regulates the molecules known to have a critical role 
in the fertilization process.  These molecules include actin, CD9, and chromosomal DNA 
(18, 61, 63).  Actin is required for further activation of the egg after sperm fusion (61).  
CD9 is a tetraspanin protein, and is expressed on the egg’s microvilli.  It is required for 
sperm fusion (46, 63, 99).  Association of egg and sperm chromosomal DNA influences 
further steps of egg activation and zygote development.  If PKC is involved in the 
regulation of these molecules, both the structure and localization of these molecules could 
be changed after PKC inhibition (by calphostin c) or activation (by PMA).  Actin, CD9, 
and chromosomal DNA were visualized by rhodamine-phalloidin, FITC-conjugated 
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secondary antibody, and DAPI respectively.  Under fluorescence microscopy, rhodamine, 
FITC, and DAPI appear red, green and blue, respectively.  A 0.1 % triton X-100 solution 
was used to permeabilize the egg membrane so that rhodamine-phalloidin could stain the 
actin inside (20, 69).  This permeabilization also allowed for the detection of any CD9 in 
the cytoplasm, although CD9 is usually found on the egg plasma membrane.  Our results 
indicated that PKC inhibition by calphostin c did not elicit any changes in the localization 
and structure of actin, CD9, and chromosomal DNA (Fig 2-9).  The actin meshwork in the 
cell cortex (just beneath the cell plasma membrane) and the actin cap (just overlying the 
egg chromosomal DNA) were not significantly changed.  CD9 was still restricted to the 
microvillus region of the egg plasma membrane.  And the egg chromosomal DNA 
appeared normally.  Similar results were obtained when eggs were treated with 2 nM PMA. 
No significant change was seen for actin, CD9 or egg chromosomal DNA.  
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Figure 2-9. DAPI (A), CD9 (B), and actin (C) staining of an egg after calphostin c 
treatment.  The arrow in A indicates the chromosome of the egg.  The two arrows in B 
show the boundaries of the microvilli (major region) and the amicrovilli (minor region) of 
the egg surface.  CD9 is restricted to the microvillus region.  The two arrows in C show the 
actin cap of the egg.  Similar staining patterns of DAPI, CD9 and actin were observed in a 
control egg. 
 
SEM imaging of the egg 
After calphostin c or PMA treatment, eggs lost their ability to be fertilized with 
sperm.  This result may come from the regulation of the microvillus structure on the egg 
surface by PKC activity.  Microvilli physically permit sperm to bind with the egg (25).  
PKC may negatively modify this structure so that the egg is not able to bind with sperm.  
To approach this question, we used electron microscopy to visualize this structure on the 
egg membrane.  Because we used toxic chemicals to fix the egg, i. e. paraformaldehyde 
and osmium, mouth pipetting was not used for transferring eggs.  Therefore, the eggs were 
attached to a glass slide so that we could change the solution, instead of transferring the 
eggs.  We made sure that the eggs had stuck on to the glass before fixation, otherwise eggs 
would not attach to the glass after fixation.  BSA in the routine culture medium does not 
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allow the living eggs to attach to the Petri dish or the slide glass.  Thus, we established a 
protocol that 30-minutes incubation of the eggs in M199 without BSA successfully 
attached the eggs on the slide glass.  In this way, the eggs would not be drained off the 
slide glass when the solution was changed with a pipette.  After fixation, dehydration, and 
coating with gold, the eggs were observed under SEM.  Normal microvillus structure and 
an amicrovillus region were clearly seen on the surface of the egg (Fig 2-9).  There was no 
difference between the calphostin c-treated egg and the control egg in both 3,500 × and 
15,000 × magnifications.  On the other hand, there was a dramatic change on the 
microvillus structure of the PMA treated egg.  The microvillus number was obviously 
reduced and the microvilli shape became distinctly longer and bigger.  
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Figure 2-10. Scanning electron microscopy (SEM) images of the drug-treated eggs.  The 
egg samples were observed with two magnifications, 3500 X (A, C, E) and 15,000 X (B, D, 
F).  Eggs treated with DMSO showed normal microvillus structure (A, B).  Calphostin c-
treated eggs also showed normal morphology of the microvillus and amicrovillus (arrow in 
C) regions (C, D).  An unusual microvillus structure was found on the egg surface after 
PMA treatment (E, F).  The microvillus number was reduced and its shape became longer.   
 
Discussion 
Several findings are revealed from the series of experiments in this study.  As was 
hypothesized, PKC activity in the mouse egg is involved in the signaling regulation of the 
egg-sperm membrane binding and fusion.  Surprisingly, we find that both inhibition and 
activation of PKC in mouse eggs results in the blockage of sperm binding and fusion, 
suggesting that PKC activity in eggs may be precisely balanced to regulate gamete 
membrane interaction in a biphasic mode.  Under fluorescence microscopy, PKC inhibition 
by calphostin c or activation by PMA did not affect the structure and localization of actin, 
CD9, and chromosomal DNA in the egg.  These molecules play an important role during 
fertilization and development of the egg (20, 46, 48, 61, 63, 69,90, 94).  Interestingly, 
under scanning electron microscopy, the structural morphology of egg surface microvilli 
was severely altered in the PMA-treated eggs, but not in the calphostin c-treated eggs. 
Both PKC inhibitors, calphostin c and staurosporine, significantly disrupted the 
egg’s ability to bind and fuse with sperm.  Staurosporine is the non-specific PKC inhibitor 
and targets many other protein kinases (15).  Therefore, compared with calphostin c, it is 
expected that 1 µM staurosporine treatment was not as effective as 1 µM calphostin c 
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treatment.  Indeed, the reduced level of FR, FI and SB in the staurosporine-treated eggs 
was less than those in the calphostin c-treated eggs.  Moreover, calphostin c induces 
irreversible PKC inhibition (31), whereas staurosporine induces a competitive and 
reversible PKC inhibition (78).  Different extent of decrease in SB and FR after these two 
drug treatment could be explained by these characteristics.  It is anticipated that there is 
still some PKC available for the eggs when they are treated with staurosporine.  When 
there is PKC available in the egg cytoplasm, egg would still hold or recover the ability for 
fertilization.   
By examining the time-course and dose-response of the calphostin c treatments, we 
found out that 1 µM calphostin c treatment for 30 minutes was required to cause significant 
inhibition of sperm binding and fusion to the egg.  A shorter treatment time or a lower 
concentration was not able to significantly block fusion and binding of sperm.  Although 
some structural or localization alterations of actin, CD9, chromosomal DNA, or microvilli 
were expected, no changes were observed under fluorescence microscopy and SEM.  
Signaling pathways that block sperm binding or fusion to the egg might be turned on or 
signaling pathways that prompt SB and FR might be turned off after PKC inhibition by 
calphostin c.  Consequently, PKC inhibition by calphostin c in mouse eggs specifically 
leads to the shut-down of sperm binding or fusion without altering other known molecules 
involved in sperm fusion and binding to the egg.  Strangely enough, other kinds of specific 
PKC inhibitors, Gö 6976 and Gö 6983, had no effect on the egg’s ability for fertilization 
with sperm.  Concentrations and treatment times applied for both drugs in this study were 
considered to effectively inhibit target PKC isoforms in mouse eggs.  This was also 
indicated in other studies (7, 17, 33, 34, 77, 88), in which many cell lines from several 
Hiroto Akabane 50 5/3/2006 
species were tested.  The reasons for this inconsistency are not clear at this moment and 
will be further investigated.   
In our hands, fertilized eggs normally show more than 60 % polyspermy rate after 
IVF.  Interestingly, we found that only 30 % of the eggs treated with 2 µM Y-27632 
showed polyspermy.  Y-27632 is a very specific inhibitor of Rho-dependent protein kinases 
(17), and shows low suppression of other kinases.  Accordingly, it is possible that Rho-
dependent protein kinases inhibited by this treatment are responsible for the reduced 
polyspermy rate.  Because SB and FR were not changed, it seems that the Y-27632 
treatment specifically blocked the second sperm from fusing.  There is a time lag between 
the first sperm fusion and the egg mechanism that refuses the second sperm.  Harmonious 
sperm fusion after sperm binding may be assisted by Rho-dependent protein kinases.  
Therefore, it would be intriguing to see whether Rho-dependent protein kinases play a role 
in facilitating the transition of sperm binding to sperm fusion. 
One remarkable observation about two PKC inhibitors (Gö 6976 and Gö 6983) was 
that the treated eggs seemly underwent immediate egg activation to form the second polar 
body after 40 minutes fertilization with sperm (Fig. 2-10).  40-50 % of fertilized eggs 
experienced this abnormal activation.  Unfertilized eggs did not display this abnormal 
activation.  This instant activation was not seen in the other IVF experiments, such as in 
the treatments of calphostin c, PMA, and DiC8.  In the previous studies, this phenomenon 
was observed 1-2 hours after insemination and pronucleus formation was confirmed 8 
hours after PKC inhibition (2 µM staurosporine) and activation (PMA and DiC8) (54, 57).  
In this study, both zona-free and zona-intact eggs treated with either Gö 6976 or Gö 6983 
did not experience pronucleus formation even after 8 hours without sperm fertilization.  
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Since both 1 µM Gö 6976 and 1 µM Gö 6983 effectively inhibit Ca2+ dependent PKC 
isoforms, cPKC, there are two possibilities considered.  The rapid activation of MII phase 
oocytes is either induced by cPKC inhibition or suppressed by cPKC activity.  
Nevertheless, it is difficult to conclude that only the cPKC isoforms, which are also 
inhibited by calphostin c, control the second polar body emission.  Moreover, it is stated 
that spindle stability and high maturation promoting factor (MPF) activity are required for 
the MII arrest of mouse oocytes (10).  Thus these drugs may affect and change microtubule 
stability or MPF activity, because they have potent actions other than PKC inhibition (17, 
77).  Not only the PKC family, but other kinases are also inhibited or activated by these 
drugs.  The significance of the observation that Gö 6976- and Gö 6983-treated eggs 
immediately emitted the second polar body after fusion with sperm remains to be 
addressed.    
     
 
 
 
 
 
 
 
Figure 2-11. Phase contrast image of inseminated eggs treated with1 µM Gö 6976.  The 
arrows show the egg’s abnormal shape, which indicates an extrusion of the second polar 
body from the egg.  This event was induced only by Gö 6976 and Gö 6983 in this study. 
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The eggs treated with PMA showed similar reduction in sperm binding and fusion 
as the eggs treated with calphostin c.  One remarkable difference between these two drugs 
is that the structure of microvilli on the egg surface was drastically changed after the PMA 
but not calphostin c treatment.  This alteration of microvilli on the egg is considered to be 
the reason for the decreased sperm binding and fusion.  From the previous data, PMA 
treatment induced pronuclear formation in both GV oocytes and MII phase eggs.  It is 
anticipated that PKC activity controls the pronuclear formation, or egg activation into an 
embryo, in mouse eggs (58).  We speculate that this promotion of eggs’ maturation and 
activation, eventually, might establish a sperm fertilization blocking system inside the egg, 
such as the alteration of the microvillus structure as seen in this study.   
Even though DiC8 treatment induced pronuclear formation in the previous report 
(58), normal sperm binding and fusion was observed in this study.  PMA induces the 
structural change of egg microvilli, which blocks sperm binding and fusion rapidly.  
However, DiC8 may not quickly enough induce the microvillus change on the egg surface.  
Different from DiC8, PMA activates ATPase and promotes cAMP formation (2, 95).  This 
ATP regulation could also modulate the egg’s fertilization ability.   
Calphostin c treatment gradually reduced sperm binding and fusion to the egg.  
However, PMA treatment suddenly destroyed the egg’s ability to bind and fuse with sperm.  
This result suggests that there might be a threshold of PKC activity.  Increase of PKC 
activity to a certain level may switch on a blocking system, which in turn totally inhibits 
fertilization of the egg.  With this respect, we speculate that the level of PKC activity 
activated by 1 nM PMA is equivalent to that activated after sperm fusion to the egg.   
 In summary, our results show that the eggs treated with both PKC activation and 
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inhibition significantly decreased their fertilization ability to bind and fuse with sperm.  
PKC inhibition by calphostin c significantly reduces sperm binding and fusion to the egg.  
However, this treatment does not affect the egg’s viability and activation (this study and 
57), nor does it shift the distribution of actin, CD9, chromosomal DNA, and microvilli.  On 
the other hand, PKC activation by PMA not only remarkably reduces sperm binding and 
fusion to the egg, but also markedly alters the number and shape of microvilli on the egg 
membrane, even though no distinct changes were observed for the localization and 
structure of actin, CD9 and chromosomal DNA.  Taken together, these results suggest that 
PKC activity in eggs may be precisely balanced to regulate gamete membrane interaction 
in a biphasic mode, and this biphasic regulation is executed through two different 
mechanisms. 
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Chapter Four 
 
Conclusions 
1. PKC inhibition by calphostin c or staurosporine in the mouse egg significantly 
diminished sperm fusion and binding.  Calphostin c did not change the microvillus 
structure on the egg surface which is considered as a critical structure for sperm-
egg membrane binding.  The data from dose-dependent curve showed that the 
higher concentration of calphostin c treatment resulted in the less sperm binding 
and fusion to the egg.  Collectively, these results sustain that PKC activity in the 
egg is necessary for sperm-egg membrane binding and fusion, highlighting that the 
PKC signaling plays a critical role during fertilization of the mouse egg and sperm.   
 
2. PKC activation by PMA in the mouse egg significantly decreased sperm fusion and 
binding.  Moreover, this treatment also markedly changed the structure of the 
microvilli on the egg surface.  PKC activation in the mouse egg is known to induce 
egg activation.  In addition, the dose-response curve from this study shows sudden 
decrease in sperm binding and fertilization rate between 500 pM to 1 nM PMA 
treatment, suggesting a threshold of PKC activity exists in the regulation of the 
egg’s ability to bind and fuse with sperm.  Sperm fusion to the egg may create a 
polyspermy blocking mechanism involving the microvillus structure.  Taken 
together, these data support the important role of PKC signaling in the regulation of 
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sperm-egg membrane binding and fusion, a view that has not been appreciated 
before. 
 
3. The localization of CD9, actin, and chromosomal DNA in the mouse egg were not 
changed by PMA or calphostin c treatment under the protocols described in this 
study.  It is possible that the regulation of these molecules may require some time 
after PKC activation or inhibition.  If so, we may miss any changes since these 
molecules were detected shortly after each drug treatment.  Alternatively, the 
regulation of these molecules may be mediated through other signaling pathways.    
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Future Directions 
 For future studies based on this research results, we can explore more pathways 
regulated by PKC signaling inside the mouse oocyte (egg). 
 Several previous studies report the automatic resumption of meiosis after PKC 
activation (57, 58).  We found that the PKC- activated egg already compromised the ability 
to bind and fuse with sperm.  Therefore, it is reasonable to hypothesize that PKC activation 
mimics the fertilization of an egg with sperm.  However, blockage of sperm binding and 
fusion to the egg by calphostin c are not expected.  For further understanding of PKC 
activity during fertilization, our research focus will be on PKC inhibition, which is still 
shrouded in mystery, rather than PKC activation. 
 PKC signaling activates many other signaling modules, such as extracellular 
signal-regulated kinase (ERK), epidermal growth factor (EGF), and mitogen-activated 
protein kinase (MAPK) (41, 42, 52, 70).  Because this complex signaling network is either 
regulating PKC or regulated by PKC, we can explore the signaling pathways downstream 
or upstream of PKC.  One previous study showed the involvement of Raf (a 
serine/threonine kinase) in oocyte development (14).  Raf is also regulated by PKC activity 
(40).  Accordingly, contribution of the Raf pathway in gamete membrane interaction is 
possible and worthy of further investigation.  Designing in vitro fertilization (IVF) 
experiments with the activation or inactivation of the Raf pathway inside the egg, we may 
clarify the participation of Raf signaling module during fertilization.   
Calcium ion is another candidate to examine its function inside the egg during 
sperm-egg membrane binding and fusion.  One subfamily of the PKC isoforms, 
conventional PKC, requires calcium to be activated, and calcium oscillation is observed 
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inside the egg after sperm fusion with the egg.  In the previous study, it has been shown 
that calcium chelator treated eggs showed polyspermy after IVF (61).  Treating eggs with 
both a PKC activator and a calcium chelator, we may identify the specific role of calcium 
ion during sperm and egg fertilization.  Furthermore, the combination of PKC 
activators/inhibitors and calcium ionophore or chelators in the treatment of mouse eggs, we 
will be able to investigate the fundamental relationship of PKC and calcium ion during 
sperm-egg binding and fusion. 
Although this study clearly demonstrates the importance of PKC pathway in the 
egg, PKC signaling may also play a role in sperm during sperm-egg membrane binding 
and fusion.  One paper suggests that the PKC signaling and calcium ion pathway are 
required for capacitation of sperm (74).  Instead of treating eggs with PKC 
activators/inhibitors, our next research experiments may be designed to investigate these 
drugs’ effects on sperm during fertilization.  To do so, capacitated sperm will be treated 
with a PKC activator or a PKC inhibitor, and then be used in the IVF assays.  Sperm may 
also be treated with a calcium ionophore/chelator to determine the involvement of calcium 
ion during sperm-egg binding and fusion.  Crosstalk of PKC and calcium ion will be also 
explored.  It is our hypothesis that PKC signaling and calcium ion inside the sperm also 
play an important role during sperm-egg membrane binding and fusion. 
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Appendix A 
Detail of Methods 
Preparing transfer pipette and zona pipette 
Eggs are small (~100 µm), delicate, and low number (80-200 eggs from 6 female 
mice) when isolated from a mouse; therefore, we have to use mouth pipettes for fine 
adjustment of the pressure to the pipettes. “Transfer-pipette” is used to transfer eggs and 
“zona-pipette” is used to remove the zona pellucida from around the eggs. These pipettes 
are made by hand in the lab. A 9” disposable Pasteur pipette tip is held and heated in an 
alcohol ramp flame until it is red in color. When the pipette becomes red and softens, take 
it out of the flame and pull both sides of the pipette. The diameter of a transfer-pipette is 
120 - 200 µm, the diameter of a zona-pipette is 50 - 100 µm (Fig. 1). Since they are very 
thin and easily broken, extra pipettes are also created. 
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Zona-pipette 
Transfer-pipette 
Zona pelucida
Zona pellucida
Egg
Egg
120-200 µm 
50 - 100 µm 
 
Figure Ap-1. 
Simple figures of the transfer and zona pipette used for this study. Depending 
on the person, the diameter of each pipette will be different. 
 
1 
2 3
4
 
Figure Ap-2.  
When a drug is put into drop 1, eggs are washed through 2, 3, and 4 (35 X 10 
mm Petri dishes are used). 100 µl of Medium 1 is used to make each drop.  
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Data figures 
Subsection A: Egg images after IVF in phase contrast and fluorescence  
Figure A-1. phase contrast image of DMSO-treated eggs after IVF.  
(November 17, 2004) 
 
 
 
 
 
 
 
 
Figure A-2. fluorescence image of DMSO-treated eggs after IVF.  
(November 17, 2004) 
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Figure A-3. phase contrast image of calphostin c-treated eggs after IVF. 
 (November 17, 2004) 
 
 
 
 
 
 
 
 
 
Figure A-4. fluorescence image of calphostin c-treated eggs after IVF.  
(November 17, 2004) 
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Figure A-5. phase contrast image of PMA-treated eggs after IVF.  
(November 17, 2004) 
 
 
 
 
 
 
 
 
 
Figure A-6. fluorescence image of PMA-treated eggs after IVF. 
 (November 17, 2004) 
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Figure A-7. phase contrast image of Gö 6976-treated eggs after IVF 
(February 25, 2005) 
 
 
 
 
 
 
 
 
 
 
 
Figure A-8. fluorescence  image of Gö 6976-treated eggs after IVF 
(February 25, 2005) 
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Figure A-9. phase contrast image of Gö 6983-treated eggs after IVF 
(February 25, 2005) 
 
 
 
 
 
 
 
 
 
Figure A-10. fluorescence image of Gö 6983-treated eggs after IVF 
(February 25, 2005) 
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Subsection B: Localization of actin, CD9, and chromosomal DNA inside 
the mouse egg  
(June 24, 2004) 
Figure B-1. actin 
Actin locatization after calphostin c 
treatment. Rhodamine-phalloidin was used to 
bisualize actin inside the egg. 
 
 
 
Figure B-2. CD9 
CD9 localization after calphostin c treatment. 
After rat anti-CD9 antibody treatment, FITC-
conjugated goat anti-rat antibody was used 
for immunohistochemistry. 
 
 
Figure B-3. chromosomal DNA 
Chromosomal DNA localization after 
calphostin c treatment. DAPI is used to stain 
the egg chromosomal DNA. 
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Subsection C: Scanning Electron Microscopy images of eggs  
(March 25, 2004) 
 
Figure C-1. control (DMSO-treated) 
egg surface (X 3500) 
 
 
 
 
 
 
 
 
 
Figure C-2. control (DMSO-reated) 
egg surface (X 15000) 
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Figure C-3. calphostin c-treated egg 
surface (X 3500) 
 
 
 
 
 
 
 
 
 
Figure C-4. calphostin c-treated egg 
surface (X 15000) 
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Figure C-5. PMA-treated egg 
surface  
(X 3500) 
 
 
 
 
 
 
 
 
 
 
Figure C-6. PMA-treated egg 
surface  
(X 15000) 
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Subsection D: Change in fertilization ability after staurosporine, 
calphostin c, and PMA treatment of mouse eggs 
 
Figure D-1. change in FR after PMA treatment of eggs 
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Figure D-2. change in FI after PMA treatment of eggs 
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Figure D-3. change in SB after PMA treatment of eggs 
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Figure D-4. change in FR after calphostin c treatment of eggs 
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Figure D-5. change in FI after calphostin c treatment of eggs 
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Figure D-6. change in SB after calphostin c treatment of eggs 
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Figure D-7. change in FR after staurosporine treatment of eggs 
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Figure D-8. change in FI after staurosporine treatment of eggs 
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Figure D-9. change in SB after staurosporine treatment of eggs 
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Figure D-10. dose-dependent effects of calphostin c to the sperm binding and fusion rate 
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Figure D-11. dose-dependenteffects of PMA to the sperm binding and fusion rate 
 
0.00
2.00
4.00
6.00
8.00
10.00
0 500 pM 1 nM 2 nM
PMA concentration
S
pe
rm
 B
in
di
ng
 (S
B)
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
Fe
rti
liz
at
io
n 
R
at
e 
(F
R)
SB
FR
 
Hiroto Akabane 88 5/3/2006 
Figure D-12. time-dependent effects of calphostin c to the sperm binding and fusion rate 
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Figure D-13. time-dependent effects of PMA to the sperm binding and fusion rate 
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Figure D-14. change in FR after Gö 6976, Gö 6983, and DiC8  treatment of eggs 
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Figure D-15. change in FI after Gö 6976, Gö 6983, and DiC8  treatment of eggs 
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Figure D-16. change in SB after Gö 6976, Gö 6983, and DiC8  treatment of eggs 
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